drugset / Trial / NCT00474123
Antiplatelet and Anti-inflammatory Effects of Statins and Ezetimibe
RandomizedParallel-groupOpen-labelTreatment
Summary
Among patients with stable coronary artery disease (CAD), it is not clear if the pleiotropic effects of cholesterol reduction differ between high-dose simvastatin alone and combined ezetimibe/simvastatin. The investigators sought to compare the anti-inflammatory and anti-platelet effects of ezetimibe 10 mg / simvastatin 20 mg (E10/S20) to simvastatin 80 mg (S80).
Timeline
- Start
- 2006-01
- Primary completion
- 2009-01
- Completion
- 2009-08
Publications
- Pesaro AE, Serrano CV Jr, Katz M, Marti L, Fernandes JL, Parra PR, Campos AH. Increasing doses of simvastatin versus combined ezetimibe/simvastatin: effect on circulating endothelial progenitor cells. J Cardiovasc Pharmacol Ther. 2013 Sep;18(5):447-52. doi: 10.1177/1074248413489771. Epub 2013 Jun 5.
- Pesaro AE, Serrano CV Jr, Katz M, Campos AH, Lopes RD, Marti LC, Martins HS, Sunahara RS, Maranhao RC, Nicolau JC. Inflammation and circulating endothelial progenitor cells in patients with coronary artery disease and residual platelet reactivity. Clinics (Sao Paulo). 2012 Sep;67(9):1117-21. doi: 10.6061/clinics/2012(09)21. No abstract available.
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Ezetimibe | Unknown | 10 mg | — |
| Comparator | Simvastatin | Small molecule | 20 mg | — |
| Comparator | Simvastatin | Small molecule | 80 mg | — |